You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 00054-0748


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00054-0748

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00054-0748 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 00054-0748

Introduction to NDC 00054-0748

The National Drug Code (NDC) 00054-0748 is a unique identifier for a specific pharmaceutical product. To conduct a thorough market analysis and price projection for this drug, it is essential to understand the drug's name, its therapeutic use, and the current market trends.

Drug Identification

While the specific drug associated with NDC 00054-0748 is not provided in the sources, it is crucial to identify the drug name and its formulation to proceed with the analysis. Typically, this information can be found in the National Drug Code Directory or through pharmaceutical databases[2].

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is facing several significant trends that can impact the pricing and market performance of any drug, including NDC 00054-0748.

Pricing and Access

Pricing and access to drugs are among the most critical issues facing the life sciences industry. C-suite executives have identified these factors as significantly affecting their strategies in 2025, with nearly half expecting a significant impact and another 49% anticipating a moderate impact[3].

Competition from Generics and Biosimilars

Competition from generic drugs and biosimilars is another key trend. About 37% of surveyed executives view this competition as a top trend, which can influence the pricing and market share of branded drugs[3].

Patent Cliff

The patent cliff, where high-revenue products lose exclusivity due to expiring patents, is a significant concern. This could lead to increased interest in mergers and acquisitions as companies seek to replace lost revenue streams[3].

Price Analysis

To analyze the price trends for NDC 00054-0748, historical pricing data is essential. Here is a general approach to how such data might be analyzed:

Historical Pricing Data

For drugs like Linezolid (NDC 00054-0319), historical pricing data shows fluctuations over time. For example, the price per unit of Linezolid 100 MG/5 ML suspension has varied from $1.82657 to $1.95344 per mL over recent months[1].

Vendor and Pricing Variations

Prices can vary depending on the vendor and the specific packaging. For instance, different vendors may offer the same drug at different prices, and the pricing can change based on the quantity and packaging[1][5].

Price Projections

Market Forces

Price projections for NDC 00054-0748 would need to consider market forces such as competition, regulatory changes, and demand. If the drug faces increased competition from generics or biosimilars, prices are likely to decrease.

Economic Factors

Economic factors, including inflation and changes in healthcare policies, can also impact pricing. For example, if there is a shift in reimbursement policies, it could affect the drug's pricing and market performance[3].

Technological Advancements

The integration of technologies like gen AI and increased use of data can boost operational efficiencies and drive innovations, potentially affecting pricing strategies. Companies that adapt to these technological advancements may have an edge in maintaining competitive pricing[3].

Regulatory Environment

FDA Regulations

The FDA plays a crucial role in regulating drug prices and access. The Drug Listing Act of 1972 requires registered drugs to have a National Drug Code (NDC), which serves as a universal product identifier[2].

Patent Expirations

Patent expirations can significantly impact the pricing of drugs. As patents expire, generic versions of the drug can enter the market, leading to price reductions[3].

Market Performance Metrics

Comparative Clinical Benefit

The market performance of a drug is often tied to its comparative clinical benefit. Drugs with higher clinical benefit scores tend to have higher early market sales. This is evident in the analysis of antimicrobial and oncology drugs, where those with higher clinical benefits achieve higher sales[4].

Sales Data

Analyzing sales data over time can provide insights into the drug's market performance. For example, the first nine quarters of sales data for newly approved drugs can indicate how well the drug is performing relative to its clinical benefit[4].

Conclusion

Key Takeaways

  • Pricing and Access: These remain critical issues in the pharmaceutical industry, influencing market strategies.
  • Competition: Generic drugs and biosimilars are significant competitors that can affect pricing.
  • Technological Advancements: Integration of technologies like gen AI can drive innovations and impact pricing.
  • Regulatory Environment: FDA regulations and patent expirations are crucial factors in drug pricing.
  • Market Performance: Comparative clinical benefit and sales data are key metrics for evaluating a drug's market performance.

FAQs

What is the National Drug Code (NDC)?

The National Drug Code (NDC) is a unique identifier for pharmaceutical products, serving as a universal product identifier.

How do patent expirations affect drug prices?

Patent expirations allow generic versions of the drug to enter the market, typically leading to a reduction in prices.

What role does the FDA play in drug pricing?

The FDA regulates drugs through the Drug Listing Act of 1972 and ensures that all registered drugs have an NDC.

How does competition from generics and biosimilars impact drug prices?

Competition from generics and biosimilars can significantly reduce the prices of branded drugs as cheaper alternatives enter the market.

What is the impact of technological advancements on drug pricing?

Technological advancements, such as the use of gen AI, can boost operational efficiencies and drive innovations, potentially affecting pricing strategies.

Sources

  1. DrugPatentWatch: Latest drug prices and trends for NDC 00054-0319.
  2. HealthData.gov: National Drug Code Directory.
  3. Deloitte Insights: 2025 life sciences outlook.
  4. ASPE: Antimicrobial drugs market returns analysis.
  5. DrugPatentWatch: Latest pharmaceutical drug prices and trends for NDC 00054-4858.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.